Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates

Bioconjugate Chemistry

Volumn 19, Issue 9, 2008, Pages 1896-1906

  Berchanski, Alexander ^a   Lapidot, Aviva ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; ARGININE; BINDING ENERGY; PROTEINS;

AMINOGLYCOSIDES; BACTERIAL ENZYMES; CELL VIABILITY; DRUG TARGETS; EUKARYOTICS; P-PROTEIN; POLYARGININE; PROTEIN SUBUNITS; RIBONUCLEASE P; VARIABLE NUMBER;

RNA;

AMINOGLYCOSIDE; AMINOGLYCOSIDE ARGININE CONJUGATE; AMINOGLYCOSIDE POLYARGININE CONJUGATE; ARGININE; BACTERIAL ENZYME; BACTERIAL RNA; FRAMYCETIN; HELIX LOOP HELIX PROTEIN; HOLOENZYME; MAGNESIUM ION; PROTEIN SUBUNIT; REV PROTEIN; RIBONUCLEASE P; RIBONUCLEOPROTEIN; TRANSFER RNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BINDING AFFINITY; CELL VIABILITY; DRUG BINDING; DRUG CONJUGATION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; EUKARYOTE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DOCKING; NONHUMAN; PROTEIN INTERACTION; RRE GENE; STRUCTURE ACTIVITY RELATION; TAR GENE;

BACTERIA (MICROORGANISMS); EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 52249097419     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800191u     Document Type: Article

References (64)

1. Ecker, D. J., and Griffey, J. (1999) RNA as a small-molecule drug target: doubling the value of genomics. Drug Discovery Today 4, 420-429.
2. Gallego, J., and Varani, G. (2001) Targeting RNA with small-molecule drugs: Therapeutic promise and chemical challenges. Acc. Chem. Res. 34, 836-843.
3. Hermann, T. (2003) Chemical and functional diversity of small molecule ligands for RNA. Biopolymers 70, 4-18.
4. Altman, S., and Kirsebom, L. (1999) Ribonuclease P, in The RNA World (Gesteland, R. F., Cech, T., and Atkins, J. F., Eds.), pp 351-380, CSH Laboratory Press, Cold Spring Harbor, NY.
5. Walker, S. C., and Engelke, D. R. (2006) Ribonuclease P; the evolution of an ancient RNA enzyme. Crit. Rev. Biochem. Mol. Biol. 41, 77-102.
6. Hall, T. A., and Brown, J. W. (2001) The ribonuclease P family. Methods Enzymol. 341, 56-77.
7. Eubank, T. D., Biswas, R., Jovanovic, M., Litovchick, A., Lapidot, A., and Gopalan, V. (2002) Inhibition of bacterial RNase P by aminoglycoside- arginine conjugates. FEBS Lett. 511, 107-112.
8. Willkomm, D. K., Gruegelsiepe, H., Goudinakis, O., Kretschmer-Kazemi Far, R., Bald, R., Erdmann, V. A., and Hartmann, R. K. (2003) Evaluation of bacterial RNase P RNA as a drug target. ChemBioChem 4, 1041-1048.
9. Walker, S. C., and Engelke, D. R. (2006) Ribonuclease P; the evolution of an ancient RNA enzyme. Crit. Rev. Biochem. Mol. Biol. 41, 77-102.
10. Kawamoto, S. A., Sudhahar, C. G., Hatfield, C. L., Sun, J., Behrman, E. J., and Gopalan, V. (2008) Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives. Nucleic Acids Res. 36, 697-704.
11. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N. R., and Altman, S. (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857.
12. Hsieh, J., Andrews, A. J., and Fierke, C. A. (2004) Roles of protein subunits in RNA-protein complexes: Lessons from ribonuclease P. Biopolymers 73, 79-89.
13. Stams, T., Niranjanakumari, S., Fierke, C. A., and Christianson, D. W. (1998) Ribonuclease P protein structure: Evolutionary origins in the translational apparatus. Science 280, 752-755.
14. Asp. Biochemistry 37, 2393-2400.
15. Kurz, J. C., and Fierke, C. A. (2002) The affinity of magnesium binding sites in the Bacillus subtilis RNase Pxpre-tRNA complex is enhanced by the protein subunit. Biochemistry 41, 9545-9558.
16. Sun, L., Campbell, F. E., Zahler, N. H., and Harris, M. E. (2006) Evidence that substrate-specific effects of C5 protein lead to uniformity in binding and catalysis by RNase P. EMBO J. 25, 3998-4007.
17. Kazantsev, A. V., Krivenko, A. A., Harrington, D. J., Carter, R. J., Holbrook, S. R., Adams, P. D., and Pace, N. R. (2003) High-resolution structure of RNase P protein from Thermotoga maritime. Proc. Natl. Acad. Sci. U.S.A. 100, 7497-7502.
18. Spitzfaden, C., Nicholson, N., Jones, J. J., Guth, S., Lehr, R., Prescott, C. D., Hegg, L. A., and Eggleston, D. S. (2000) The structure of ribonuclease P protein from Staphylococcus aureus reveals a unique binding site for single-stranded RNA. J. Mol. Biol. 295, 105-115.
19. Altman, S. (1989) Ribonuclease P: An enzyme with a catalytic RNA subunit. Adv. Enzymol. Relat. Areas Mol. Biol. 62, 1-36.
20. Gopalan, V., Baxevanis, A. D., Landsman, D., and Altman, S. (1997) Analysis of the functional role of conserved residues in the protein subunit of ribonuclease P from Escherichia coli. J. Mol. Biol. 267, 818-829.
21. Jovanovic, M., Sanchez, R., Altman, S., and Gopalan, V. (2002) Elucidation of structure-function relationships in the protein subunit of bacterial RNase P using a genetic complementation approach. Nucleic Acids Res. 30, 5065-5073.
22. Silva, J. G., and Carvalho, I. (2007) New insights into aminoglycoside antibiotics and derivatives. Curr. Med. Chem. 14, 1101-1119.
23. Tok, J. B., Cho, J., and Rando, R. R. (1999) Aminoglycoside antibiotics are able to specifically bind the 5′- untranslated region of thymidylate synthase messenger RNA. Biochemistry 38, 199-206.
24. Mikkelsen, N. E., Johansson, K., Virtanen, A., and Kirsebom, L. A. (2001) Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complex. Nat. Struct. Biol. 8, 510-514.
25. Delling, U., Roy, S., Sumner-Smith, M., Barnett, R., Reid, L., Rosen, C. A., and Sonenberg, N. (1991) The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA. Proc. Natl. Acad. Sci. U.S.A. 88, 6234-6238.
26. Zapp, M. L., Stern, S., and Green, M. R. (1993) Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74, 969-978.
27. Wang, S., Huber, P. W., Cui, M., Czarnik, A. W., and Mei, H. Y. (1998) Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry 37, 5549-5557.
28. Mikkelsen, N. E., Brannvall, M., Virtanen, A., and Kirsebom, L. A. (1999) Inhibition of RNase P RNA cleavage by aminoglycosides. Proc. Natl. Acad. Sci. U.S.A. 96, 6155-6160.
29. Puglisi, J. D., Chen, L., Frankel, A. D., and Williamson, J. R. (1993) Role of RNA structure in arginine recognition of TAR RNA. Proc. Natl. Acad. Sci. U.S.A. 90, 3680-3684.
30. Litovchick, A., Evdokimov, A. G., and Lapidot, A. (1999) Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro. FEBS Lett. 445, 73-79.
31. Litovchick, A., Evdokimov, A. G., and Lapidot, A. (2000) Aminoglycoside-arginine conjugates that bind TAR RNA: Synthesis, characterization, and antiviral activity. Biochemistry 39, 2838-2852.
32. Litovchick, A., Lapidot, A., Eisenstein, M., Kalinkovich, A., and Borkow, G. (2001) Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: Synthesis and anti-HIV activities. Biochemistry 40, 15612-15623.
33. Borkow, G., Vijayabaskar, V., Lara, H. H., Kalinkovich, A., and Lapidot, A. (2003) Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step. Antiviral Res. 60, 181-192.
34. Borkow, G., Lara, H. H., and Lapidot, A. (2003) Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate. Biochem. Biophys. Res. Commun. 312, 1047-1052.
35. Lapidot, A., Vijayabaskar, V., Litovchick, A., Yu, J., and James, T. L. (2004) Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy. FEBS Lett. 577, 415-421.
36. Borkow, G., and Lapidot, A. (2005) Multi-targeting the entrance door to block HIV-1. Curr. Drug Targets: Infect. Disord. 5, 3-15.
37. Carriere, M., Vijayabaskar, V., Applefield, D., Harvey, I., Garneau, P., Lorsch, J., Lapidot, A., and Pelletier, J. (2002) Inhibition of protein synthesis by aminoglycoside-arginine conjugates. RNA 8, 1267-1279.
38. Weeks, K. M., Ampe, C., Schultz, S. C., Steitz, T. A., and Crothers, D. M. (1990) Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 249, 1281-1285.
39. Cheng, A. C., Calabro, V., and Frankel, A. D. (2001) Design of RNA-binding proteins and ligands. Curr. Opin. Struct. Biol. 11, 478-484.
40. Berchanski, A., and Lapidot, A. (2007) Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure. BBA-Biomembranes 1768, 2107-2119.
41. Hegde, R., Borkow, G., Berchanski, A., and Lapidot, A. (2007) Structure-function relationship of novel X4 HIV-1 entry inhibitors: L- and D-arginine peptides-aminoglycoside conjugates. FEBS J. 274, 6523-6536.
42. Massire, C., Jaeger, L., and Westhof, E. (1998) Derivation of the three-dimensional architecture of bacterial ribonuclease P RNAs from comparative sequence analysis. J. Mol. Biol. 279, 773-793.
43. Tsai, H. Y., Masquida, B., Biswas, R., Westhof, E., and Gopalan, V. (2003) Molecular modeling of the three-dimensional structure of the bacterial RNase P holoenzyme. J. Mol. Biol. 325, 661-675.
44. Altman, S. (2007) A view of RNase P. Mol. BioSyst. 3, 604-607.
45. Kazantsev, A. V., Krivenko, A. A., Harrington, D. J., Holbrook, S. R., Adams, P. D., and Pace, N. R. (2005) Crystal structure of a bacterial ribonuclease P RNA. Proc. Natl. Acad. Sci. U.S.A. 102, 13392-13397.
46. Torres-Larios, A., Swinger, K. K., Krasilnikov, A. S., Pan, T., and Mondragon, A. (2005) Crystal structure of the RNA component of bacterial ribonuclease P. Nature 437, 584-587.
47. Niranjanakumari, S., Day-Storms, J. J., Ahmed, M., Hsieh, J., Zahler, N. H., Venters, R. A., and Fierke, C. A. (2007) Probing the architecture of the B. subtilis RNase P holoenzyme active site by cross-linking and affinity cleavage. RNA 13, 521-535.
48. Kitchen, D. B., Decornez, H., and Bajorath, J. (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nature Rev. 3, 935-949.
49. Faber, C., Sticht, H., Schweimer, K., and Rosch, P. (2000) Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B. J. Biol. Chem. 275, 20660-20666.
50. Berchanski, A., Shapira, B., and Eisenstein, M. (2004) Hydrophobic complementarity in protein-protein docking. Proteins 56, 130-142.
51. Heifetz, A., Katchalski-Katzir, E., and Eisenstein, M. (2002) Electrostatics in protein-protein docking. Protein Sci. 11, 571-587.
52. Zahler, N. H., Sun, L., Christian, E. L., and Harris, M. E. (2005) The Pre-tRNA Nucleotide Base and 2′-Hydroxyl at N(-1) Contribute to Fidelity in tRNA Processing by RNase P. J. Mol. Bio.l 345, 969-985.
53. Pan, T., Loria, A., and Zhong, K. (1995) Probing of tertiary interactions in RNA: 2′-Hydroxyl-base contacts between the RNase P RNA and pre-tRNA. Proc. Natl. Acad. Sci. U.S.A. 92, 12510-12514.
54. Christian, E. L., Smith, K. M., Perera, N., and Harris, M. E. (2006) The P4 metal binding site in RNase P RNA affects active site metal affinity through substrate positioning. RNA 12, 1463-1467.
55. Kaye, N. M., Christian, E. L., and Harris, M. E. (2002) NAIM and site-specific functional group modification analysis of RNase P RNA: magnesium dependent structure within the conserved P1-P4 multihelix junction contributes to catalysis. Biochemistry 41, 4533-4545.
56. Getz, M. M., Andrews, A. J., Fierke, C. A., and Al-Hashimi, H. M. (2007) Structural plasticity and Mg2+ binding properties of RNase P P4 from combined analysis of NMR residual dipolar couplings and motionally decoupled spin relaxation. RNA 13, 251-266.
57. Buck, A. H., Dalby, A. B., Poole, A. W., Kazantsev, A. V., and Pace, N. R. (2005) Protein activation of a ribozyme: the role of bacterial RNase P protein. EMBO J. 24, 3360-3368.
58. Kirsebom, L. A. (2007) RNase P RNA mediated cleavage: substrate recognition and catalysis. Biochimie 89, 1183-1194.
59. Kufel, J., and Kirsebom, L. A. (1998) The P15-loop of Escherichia coli RNase P RNA is an autonomous divalent metal ion binding domain. RNA 4, 777-788.
60. Rueda, D., Hsieh, J., Day-Storms, J. J., Fierke, C. A., and Walter, N. G. (2005) The 5′ leader of precursor tRNAAsp bound to the Bacillus subtilis RNase P holoenzyme has an extended conformation. Biochemistry 44, 16130-16139.
61. Cabrera, C., Gutierrez, A., Blanco, J., Barretina, J., Litovchick, A., Lapidot, A., Evdokimov, A. G., Clotet, B., and Este, J. A. (2000) Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection. AIDS Res. Hum. Retroviruses 16, 627-634.
62. Baker, T. J., Luedtke, N. W., Tor, Y., and Goodman, M. (2000) Synthesis and anti-HIV activity of guanidinoglycosides. J. Org. Chem. 65, 9054-9058.
63. Wang, Y., Hamasaki, K., and Rando, R. R. (1997) Specificity of aminoglycoside-binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region. Biochemistry 36, 768-779.
64. Lapidot, A., Vijayabaskar, V and Borkow, G. (2004) Amino-Modified Polysaccharides and Methods of Generating and Using Same, US Patent 10/831,224[PCT 2003027-00-01].